Introduction
• The morning hours are a difficult time for patients with chronic obstructive pulmonary disease (COPD).
• COPD symptoms are commonly experienced in the morning.
• Patients have reported that morning is the time of day when their symptoms are the most troublesome. [1] [2] [3] • Morning symptoms have been reported to limit morning activities of daily living 3 which, in turn, may have a negative impact on quality of life. 4 • Two patient reported outcome (PRO) instruments have been used in clinical trials 4, 7 to collect data about early morning symptoms. However, the published literature about these instruments suggests that they may not have been developed with sufficient evidence of content validity in order to make their development consistent with the US Food and Drug Administration's requirements 6 of a patient-reported outcome (PRO) instrument to collect data to support label claims. The two instruments were:
• The Global Chest Symptoms Questionnaire (GCSQ) 4, 5 • Used to assess COPD symptoms in the morning (pre-and post-morning dose)
• The Capacity of Daily Living during the Morning (CDLM) 4, 5 • Used to capture the effect of medications on morning activities.
Objectives
• The objective of this study was to develop and test a PRO instrument that:
• assesses patients' experience of COPD symptoms during the early morning
• meets the evidence requirements for content validity, as described in the FDA PRO Guidance
• can be used to collect data in clinical trials to support treatment benefit claims
Methods
• This study used the methods recommended for concept elicitation, item generation, and cognitive debriefing interviews as described in the FDA Guidance for Industry on Patient Reported Outcome Measures. 6 • The methods used are described in Figure 1 . Four focus groups were conducted with a total of 27 patients, to understand patients' experience of early morning symptoms including specific symptoms, variation in severity, and consequences of the symptoms.
Analysis of Data from Qualitative Work
Transcripts from focus group audio-recordings were analyzed using ATLAS.ti, using a coding dictionary. Patient statements were categorized according to concepts and themes; saturation of concepts was explored.
Item Generation
Items for the PRO instrument were developed to evaluate the symptoms and impacts noted by focus group participants, using terminology directly from patient quotes.
Translatability Review
An electronic PRO (ePRO) and linguistics expert reviewed the diary items to enhance the clarity and potential translatability of the items to different languages and electronic formats.
Cognitive Debriefing Interviews
One-on-one cognitive debriefing interviews were conducted with 10 COPD patients by a trained interviewer and were audio-recorded.
Analysis of Interviews and Revisions to the Instrument
Transcripts from the interview audio-recordings were analyzed using ATLAS.ti. Results were reviewed, and a few items were refined to enhance clarity. An Item Tracking Matrix was developed to document changes to the items.
Development of a Preliminary Conceptual Framework

Development of a Discussion Guide for Concept Elicitation Focus Groups Clinician Interviews
Interviews with six clinicians with expertise in pulmonary medicine or sleep medicine
Concept Elicitation
Item Generation
Confirmation of Content Validity
Results
Literature Review
• Core symptoms of COPD in the early morning were identified:
• Clinician Interviews
• The clinicians indicated that:
• Early morning symptoms of COPD are underreported by patients.
• Morning symptoms of COPD are likely to be more bothersome than nighttime symptoms.
• Many patients experience both nighttime and early morning symptoms.
• Morning symptoms are tied to the ability of patients to perform activities.
• Results of the literature review and clinician interviews informed the development of the focus group discussion guide. This ensured comprehensive concept elicitation from the patient.
Description of Sample
• Four focus groups were conducted with 27 patients in Long Island, NY, Hampton Roads, VA, San Antonio, TX, and Raleigh, NC.
• After focus group data were analyzed and items generated, ten cognitive debriefing interviews were conducted in Richmond, VA. 
Concept Elicitation
• Concepts that reflect patients' experience of early morning symptoms of COPD and impacts of those symptoms on patients' daily activities were identified through the analyses of focus groups' transcripts.
• Key concepts were confirmed by participants in subsequent discussions and no new emerging concepts were mentioned, thus saturation of concepts was reached.
• A saturation grid depicting emergent early morning symptoms of COPD and the impact of these symptoms are shown in Table 2 .
• The focus groups uncovered all relevant patient experiences of early morning symptoms of COPD. • Items were generated to cover concepts in the framework using patient terminology. A few examples of item generation are given in Table 3 . 408: When I first get up-coughing.
Saturation Grids
Did you experience any of the following this morning?
• Cough Phlegm 401: Usually, when I wake after sleeping all night, I will have phlegm that will-I'll need to clear airways so I-I'll cough. Sometimes it'll bring up phlegm, sometimes not.
• Difficulty bringing up phlegm
Congestion
[I]s there anything that sort of triggers that mucus in the morning or that coughing?
207: It's congested, tight, just normal nasty feeling.
• Chest congestion • Participant feedback from cognitive debriefing interviews were used to revise the measure. One example of this modification is shown in Table 5 . 
Conclusions
• A new PRO measure has been developed to evaluate early morning symptoms of COPD.
• The measure was developed using the methodology outlined in the FDA requirements for use in clinical trials to support label claims.
• Evidence of content validity of the measure has been documented.
Future Directions
• The sample was limited in terms of ethnic diversity. The
relevance of concepts will be tested in a more diverse sample during additional patient testing (e.g. usability testing).
• An electronic version of the measure is being developed and tested for use in clinical trials.
• Psychometric testing, including item reduction and evaluation of measurement properties, is planned for the current EMSCI.
